Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling
Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially serious adverse effect of a wide range of chemotherapeutics. The lack of understanding of the molecular mechanisms underlying CIPN limits the efficacy of chemotherapy and development of therapeutics for treatment and preve...
Main Authors: | Christina Mortensen, Nanna Elman Andersen, Tore Bjerregaard Stage |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/16/3939 |
Similar Items
-
Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
by: Sandy Eldridge, et al.
Published: (2021-11-01) -
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
by: Martin W. Nicholson, et al.
Published: (2022-06-01) -
Perspective on Schwann Cells Derived from Induced Pluripotent Stem Cells in Peripheral Nerve Tissue Engineering
by: Zhong Huang, et al.
Published: (2020-11-01) -
Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer’s disease
by: Kaitlin Flannagan, et al.
Published: (2023-08-01) -
Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes
by: Sebastian W. Nielsen, et al.
Published: (2022-03-01)